BioCentury
ARTICLE | Politics & Policy

CMS proposes to guarantee 3 years of pass-through payments

July 8, 2016 1:02 AM UTC

CMS is proposing to guarantee three years of "pass-through" payments for new devices, drugs, biologics and radiopharmaceuticals while the agency collects data to incorporate the cost of innovative products into payment rates.

Currently, CMS provides transitional pass-through payments for 2-3 years, but the exact length of time varies depending on when during the year a product is approved. Pass-through status is determined on a quarterly basis but expires at the end of the calendar year once CMS has made at least two years of pass-through payments. ...